A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

Amgen acquires Dark Blue Therapeutics for up to $840 million, adding early-stage leukemia drug research and strengthening its oncology discovery pipeline.

Enliven Therapeutics (EVN) stock jumps as the company post initial early-stage trial data for its lead asset ELVN-001 in ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Daiichi Sankyo is eying new horizons for its leukemia med Vanflyta, with Genesis Pharma signing on to commercialize the drug ...

ORLANDO, Fla. - Gleevec, a cancer pill making headlines in recent years because of its remarkable effects against leukemia, may stop the disease from progressing to a deadly stage, doctors said today.

For some leukemia patients who have had trouble responding to certain types of cancer therapies, there may still be hope for an effective and possibly permanent treatment. Revumenib is an experimental ...

Cancer drug revumenib passed a pivotal test of its efficacy in patients with a hard-to-treat form of leukemia, drugmaker Syndax Pharmaceuticals said Monday. The Phase 2 AUGMENT-101 trial met its ...

Some hospitals report having enough of the drug; others say supplies are low. April 14, 2011— -- ABC News heard from dozens of medical centers on reported shortages of the leukemia drug ...

Syndax Pharmaceuticals’ treatment for a genetically defined form of advanced leukemia met its goal in a pivotal study, leading to complete remission for about a quarter of patients in the trial. The ...